Lefitolimod is under investigation in clinical trial NCT03837756 (Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.